iCAD INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 39 rows in 2018. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2018-12-31: Reporting owner Patel Rakesh; Form 4; Security Director Stock Option (right to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2018-12-31: Reporting owner Wood Susan Alyson; Form 4; Security Director Stock Option (right to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2018-12-31: Reporting owner SASSINE ANDY; Form 4; Security Director Stock Option (right to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2018-12-31: Reporting owner SASSINE ANDY; Form 4; Security Director Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2018-12-31 | Patel Rakesh Director | 4 | Director Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,315 0 owned after | $3.70 exercise price | 2023-03-09 | |
| 2018-12-31 | Wood Susan Alyson Director | 4 | Director Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,738 0 owned after | $3.70 exercise price | 2023-03-09 | |
| 2018-12-31 | SASSINE ANDY Director | 4 | Director Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −9,321 0 owned after | $3.70 exercise price | 2023-03-09 | |
| 2018-12-31 | SASSINE ANDY Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,321 9,321 owned after | $3.70 exercise price | 2019-01-02 | |
| 2018-12-31 | Brem Rachel Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,122 7,122 owned after | $3.70 exercise price | 2019-01-02 | |
| 2018-12-31 | Patel Rakesh Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,315 8,315 owned after | $3.70 exercise price | 2019-01-02 | |
| 2018-12-31 | Wood Susan Alyson Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,738 8,738 owned after | $3.70 exercise price | 2019-01-02 | |
| 2018-11-16 | Patel Rakesh Director | 4 | Director Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −40,000 0 owned after | $2.89 exercise price | 2023-03-09 | |
| 2018-11-16 | Klein Michael S Director | 4 | Director Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −90,000 0 owned after | $2.89 exercise price | 2023-03-09 | |
| 2018-11-16 | Wood Susan Alyson Director | 4 | Director Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −40,000 0 owned after | $2.89 exercise price | 2023-03-09 | |
| 2018-11-16 | Klein Michael S Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +559,809 559,809 owned after | $2.89 exercise price | 2018-11-20 | |
| 2018-11-16 | Patel Rakesh Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $2.89 exercise price | 2018-11-20 | |
| 2018-11-16 | Wood Susan Alyson Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $2.89 exercise price | 2018-11-20 | |
| 2018-11-02 holding as of filing | Patel Rakesh Director | 3 | Options to Purchase Common Stock Derivative · Direct | Holding | $8.66 exercise price | 2018-11-02 | ||
| 2018-09-28 | SASSINE ANDY Director | 4 | Director Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,517 0 owned after | $2.91 exercise price | 2023-03-09 | |
| 2018-09-28 | Subramaniam Somu Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,983 6,983 owned after | $2.91 exercise price | 2018-10-02 | |
| 2018-09-28 | RAPPAPORT STEVEN N Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,707 10,707 owned after | $2.91 exercise price | 2018-10-02 | |
| 2018-09-28 | Goodman Robert L Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,517 6,517 owned after | $2.91 exercise price | 2018-10-02 | |
| 2018-09-28 | Brem Rachel Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,914 7,914 owned after | $2.91 exercise price | 2018-10-02 | |
| 2018-09-28 | HOWARD DR LAWRENCE Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +13,035 13,035 owned after | $2.91 exercise price | 2018-10-02 | |
| 2018-09-28 | SUSSMAN ELLIOT J MD MBA Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,707 10,707 owned after | $2.91 exercise price | 2018-10-02 | |
| 2018-09-28 | SASSINE ANDY Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,517 6,517 owned after | $2.91 exercise price | 2018-10-02 | |
| 2018-09-28 | Ecock Anthony F Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,310 9,310 owned after | $2.91 exercise price | 2018-10-02 | |
| 2018-06-29 | SASSINE ANDY Director | 4 | Director Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,219 0 owned after | $3.05 exercise price | 2023-03-09 | |
| 2018-06-29 | RAPPAPORT STEVEN N Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,217 10,217 owned after | $3.05 exercise price | 2018-07-02 | |
| 2018-06-29 | SASSINE ANDY Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,219 6,219 owned after | $3.05 exercise price | 2018-07-02 | |
| 2018-06-29 | HOWARD DR LAWRENCE Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,438 12,438 owned after | $3.05 exercise price | 2018-07-02 | |
| 2018-06-29 | Ecock Anthony F Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,885 8,885 owned after | $3.05 exercise price | 2018-07-02 | |
| 2018-06-29 | Subramaniam Somu Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,440 8,440 owned after | $3.05 exercise price | 2018-07-02 | |
| 2018-06-29 | Brem Rachel Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,552 7,552 owned after | $3.05 exercise price | 2018-07-02 | |
| 2018-06-29 | Goodman Robert L Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,219 6,219 owned after | $3.05 exercise price | 2018-07-02 | |
| 2018-06-29 | SUSSMAN ELLIOT J MD MBA Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,217 10,217 owned after | $3.05 exercise price | 2018-07-02 | |
| 2018-03-30 | SUSSMAN ELLIOT J MD MBA Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,275 10,275 owned after | $3.08 exercise price | 2018-04-03 | |
| 2018-03-30 | Subramaniam Somu Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,488 8,488 owned after | $3.08 exercise price | 2018-04-03 | |
| 2018-03-30 | RAPPAPORT STEVEN N Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,275 10,275 owned after | $3.08 exercise price | 2018-04-03 | |
| 2018-03-30 | HOWARD DR LAWRENCE Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,509 12,509 owned after | $3.08 exercise price | 2018-04-03 | |
| 2018-03-30 | Goodman Robert L Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,254 6,254 owned after | $3.08 exercise price | 2018-04-03 | |
| 2018-03-30 | Ecock Anthony F Director | 4 | Director Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,935 8,935 owned after | $3.08 exercise price | 2018-04-03 | |
| 2018-03-30 | Brem Rachel Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,595 7,595 owned after | $3.08 exercise price | 2018-04-03 |